Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Research & Development

Allergan Receives Approval for Ozurdex in China for the Treatment of Retinal Vein Occlusion (RVO)

Research & Development
Allergan plc announced that it has received an Imported Drugs License (IDL) from the Chinese FDA to market Ozurdex® (dexamethasone intravitreal implant 0.7 mg)...

Biogen And Eisai Expand Existing Collaboration Agreement To Develop And Commercialize Investigational for Alzheimer’s Disease Treatments

Research & Development
Eisai Co., Ltd. and Biogen Inc. announced that the companies have expanded their existing agreement to jointly develop and commercialize investigational Alzheimer's disease treatments....

ViiV Healthcare announces positive results from phase III BRIGHTE study of fostemsavir in HTE patients with HIV-1 infection

Research & Development
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi Limited as shareholders, announced results from the phase III...

Nicholas Shackley joins to Lead our Pharmaceutical Contract Development and Manufacturers Services Business

Research & Development
In this role Nicholas will lead Johnson Matthey's (JM) custom development and manufacturing offering to pharmaceutical and biotechnology customers who are developing novel therapies...

UK Nod For Gene Therapy, GSK Wins U.S. Shingles Vaccine Approva

Research & Development
GlaxoSmithKline has won U.S. approval for a new and improved shingles vaccine, the second of three key products for which the British drugmaker expects...

Nicholas Shackley joins to Lead our Pharmaceutical Contract Development and Manufacturers Services Business

Research & Development
We are pleased to announce the appointment of Nicholas Shackley to the role of Global Vice President Innovator Products and Solutions. In this role Nicholas...

U.S. FDA Grants Fast Track Designation to Astellas for Development of Gilteritinib in Relapsed or Refractory Acute Myeloid Leukemia

Research & Development
Astellas Pharma Inc. announced that the U.S. FDA has granted Fast Track designation for the development of gilteritinib for adult patients with FLT3 mutation-positive...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

Whitepapers 0
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

Whitepapers 0
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Whitepapers 0
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

About us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

Resources

Advertise

Subscribe

Copyright © Value Media Group 2026. All rights reserved.